000 01681 a2200493 4500
005 20250517093609.0
264 0 _c20170421
008 201704s 0 0 eng d
022 _a1539-2864
024 7 _a10.1097/IAE.0000000000001063
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZheng, Andrew
245 0 0 _aCOMBINED VITRECTOMY AND INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_cNov 2016
300 _a2087-2092 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCombined Modality Therapy
650 0 4 _aDexamethasone
_xadministration & dosage
650 0 4 _aDrug Implants
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aIntraocular Pressure
_xphysiology
650 0 4 _aIntravitreal Injections
650 0 4 _aMacular Edema
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetinal Vein Occlusion
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aTomography, Optical Coherence
650 0 4 _aUveitis, Posterior
_xdrug therapy
650 0 4 _aVisual Acuity
_xphysiology
650 0 4 _aVitrectomy
_xmethods
650 0 4 _aWet Macular Degeneration
_xdrug therapy
700 1 _aChin, Eric K
700 1 _aAlmeida, David R P
700 1 _aTsang, Stephen H
700 1 _aMahajan, Vinit B
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 36
_gno. 11
_gp. 2087-2092
856 4 0 _uhttps://doi.org/10.1097/IAE.0000000000001063
_zAvailable from publisher's website
999 _c25991105
_d25991105